Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot…
Bebuzee (OTC: BBUZ), a pioneer in the social platform and streaming service industry, today announced that it is moving beyond…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs,…
Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), an exploration company targeting magmatic nickel sulphide discoveries to support the rapidly growing…
SUIC Worldwide Holdings (OTC: SUIC), a publicly traded technology company, and its I.Hart Group Taiwan Ltd. have signed a franchise…
Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to…
Duke reports that physician-patient relationships can have profound positive and negative implications on clinical care” The dynamic between a physician…
CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company advancing its lead drug candidate, Berubicin, along the pathway to potential regulatory…
Longeveron (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a…
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a disruptive company leveraging advanced alcohol detection approaches and technologies, recently published three case studies…